These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26274561)

  • 1. Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation.
    Šolman M; Ligabue A; Blaževitš O; Jaiswal A; Zhou Y; Liang H; Lectez B; Kopra K; Guzmán C; Härmä H; Hancock JF; Aittokallio T; Abankwa D
    Elife; 2015 Aug; 4():e08905. PubMed ID: 26274561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold.
    Posada IM; Serulla M; Zhou Y; Oetken-Lindholm C; Abankwa D; Lectez B
    PLoS One; 2016; 11(7):e0159677. PubMed ID: 27437940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic Screening Identifies Protein Synthesis Inhibitors as H-Ras-Nanocluster-Increasing Tumor Growth Inducers.
    Najumudeen AK; Posada IM; Lectez B; Zhou Y; Landor SK; Fallarero A; Vuorela P; Hancock J; Abankwa D
    Biochemistry; 2015 Dec; 54(49):7212-21. PubMed ID: 26568031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of Raf kinase recruitment to the GTPase H-ras depends on H-ras membrane conformer-specific nanoclustering.
    Guzmán C; Šolman M; Ligabue A; Blaževitš O; Andrade DM; Reymond L; Eggeling C; Abankwa D
    J Biol Chem; 2014 Apr; 289(14):9519-33. PubMed ID: 24569991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAS variant signalling.
    Mo SP; Coulson JM; Prior IA
    Biochem Soc Trans; 2018 Oct; 46(5):1325-1332. PubMed ID: 30287508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated K-RAS and its effect on morphological appearance.
    Kiyokawa E; Minato H
    J Biochem; 2014 Sep; 156(3):137-45. PubMed ID: 24958732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FLIM-FRET Analysis of Ras Nanoclustering and Membrane-Anchorage.
    Parkkola H; Siddiqui FA; Oetken-Lindholm C; Abankwa D
    Methods Mol Biol; 2021; 2262():233-250. PubMed ID: 33977480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapalogs can promote cancer cell stemness in vitro in a Galectin-1 and H-ras-dependent manner.
    Posada IMD; Lectez B; Sharma M; Oetken-Lindholm C; Yetukuri L; Zhou Y; Aittokallio T; Abankwa D
    Oncotarget; 2017 Jul; 8(27):44550-44566. PubMed ID: 28562352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renewed battle against RAS-mutant cancers.
    Zhang F; Cheong JK
    Cell Mol Life Sci; 2016 May; 73(9):1845-58. PubMed ID: 26892781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-1 is a novel structural component and a major regulator of h-ras nanoclusters.
    Belanis L; Plowman SJ; Rotblat B; Hancock JF; Kloog Y
    Mol Biol Cell; 2008 Apr; 19(4):1404-14. PubMed ID: 18234837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering.
    Blaževitš O; Mideksa YG; Šolman M; Ligabue A; Ariotti N; Nakhaeizadeh H; Fansa EK; Papageorgiou AC; Wittinghofer A; Ahmadian MR; Abankwa D
    Sci Rep; 2016 Apr; 6():24165. PubMed ID: 27087647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleophosmin and nucleolin regulate K-Ras plasma membrane interactions and MAPK signal transduction.
    Inder KL; Lau C; Loo D; Chaudhary N; Goodall A; Martin S; Jones A; van der Hoeven D; Parton RG; Hill MM; Hancock JF
    J Biol Chem; 2009 Oct; 284(41):28410-28419. PubMed ID: 19661056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo.
    Steven A; Heiduk M; Recktenwald CV; Hiebl B; Wickenhauser C; Massa C; Seliger B
    Mol Cancer Res; 2015 Aug; 13(8):1248-62. PubMed ID: 25934695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic Ras Isoforms Signaling Specificity at the Membrane.
    Nussinov R; Tsai CJ; Jang H
    Cancer Res; 2018 Feb; 78(3):593-602. PubMed ID: 29273632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal anti-inflammatory drugs alter the spatiotemporal organization of Ras proteins on the plasma membrane.
    Zhou Y; Cho KJ; Plowman SJ; Hancock JF
    J Biol Chem; 2012 May; 287(20):16586-95. PubMed ID: 22433858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction. Prelude to an anniversary for the RAS oncogene.
    Downward J
    Science; 2006 Oct; 314(5798):433-4. PubMed ID: 17053139
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel determinants of H-Ras plasma membrane localization and transformation.
    Willumsen BM; Cox AD; Solski PA; Der CJ; Buss JE
    Oncogene; 1996 Nov; 13(9):1901-9. PubMed ID: 8934536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras nanoclusters: Versatile lipid-based signaling platforms.
    Zhou Y; Hancock JF
    Biochim Biophys Acta; 2015 Apr; 1853(4):841-9. PubMed ID: 25234412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Ras Membrane Organization and Signaling: Ras Rocks Again.
    Abankwa D; Gorfe AA
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33172116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RAS-Effector Interaction as a Drug Target.
    Keeton AB; Salter EA; Piazza GA
    Cancer Res; 2017 Jan; 77(2):221-226. PubMed ID: 28062402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.